Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50 copies/ml HIV-1 RNA

Journal of Clinical Virology

Volumn 46, Issue 4, 2009, Pages 367-370

  Baroncelli, Silvia ^a   Galluzzo, Clementina Maria ^a   Pirillo, Maria Franca ^a   Mancini, Maria Grazia ^a   Weimer, Liliana Elena ^a   Andreotti, Mauro ^a   Amici, Roberta ^a   Vella, Stefano ^a   Giuliano, Marina ^a   Palmisano, Lucia ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

HAART; HIV infection; Lipopolysaccharide; Microbial translocation; Viral suppression

Indexed keywords

ANTIRETROVIRUS AGENT; BACTERIAL DNA; LIPOPOLYSACCHARIDE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; AGED; ARTICLE; BACTERIAL TRANSLOCATION; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VIREMIA; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTERIA; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LIPOPOLYSACCHARIDES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RNA, VIRAL; VIRUS REPLICATION;

EID: 71549143183     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.09.011     Document Type: Article

References (14)

1. Ancuta P., Kamat A., Kunstman K.J., Kim E.Y., Autissier P., Wurcel A., et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3 (2008) e2516
2. Marchetti G., Bellistrì G.M., Borghi E., Tincati C., Ferramosca S., La Francesca M., et al. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 22 (2008) 2035-2038
3. Brenchley J.M., and Douek D.C. HIV infection and the gastrointestinal immune system. Mucosal Immunol 1 (2008) 23-30
4. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12 (2006) 1365-1371
5. Balagopal A., Philp F.H., Astemborski J., Block T.M., Mehta A., Long R., et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology 135 (2008) 226-233
6. Jiang W., Lederman M.M., Hunt P., Sieg S.F., Haley K., Rodriguez B., et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 199 (2009) 1177-1185
7. Palmisano L., Giuliano M., Bucciardini R., Fragola V., Andreotti M., Galluzzo C., et al. Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) study. J Acquir Immune Defic Syndr 46 (2007) 39-47
8. Palmisano L., Giuliano M., Nicastri E., Pirillo M.F., Andreotti M., Galluzzo C.M., et al. Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapy. AIDS 19 (2005) 1843-1847
9. Epple H.J., Schneider T., Troeger H., Kunkel D., Allers K., Moos V., et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 58 (2009) 220-227
10. Papasavvas E., Pistilli M., Reynolds G., Bucki R., Azzoni L., Chehimi J., et al. Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients. AIDS 23 (2009) 369-375
11. Palmisano L., Giuliano M., Chiarotti F., Zanchetta M., Andreotti M., Pirillo M.F., et al. Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapy. J Acquir Immune Defic Syndr 48 (2008) 68-71
12. Palmisano L., Giuliano M., Galluzzo C.M., Amici R., Andreotti M., Weimer L.E., et al. The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy. HIV Med. 10 (2009) 477-481
13. Ananworanich J., Gayet-Ageron A., Le Braz M., Prasithsirikul W., Chetchotisakd P., Kiertiburanakul, et al. CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. Lancet 368 (2006) 459-465
14. Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr W.M., Lundgren J.D., Neaton J.D., Gordin F., Abrams D., et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 355 (2006) 2283-2296